AstraZeneca's Seroquel XR Ruled Valid And Infringed
A New Jersey federal judge on Thursday found that four generics makers infringed an AstraZeneca PLC patent on the anti-psychotic Seroquel XR, effectively clearing the path for AstraZeneca to sell the...To view the full article, register now.
Already a subscriber? Click here to view full article